Cargando…
Efficacy of Chest CT for COVID-19 Pneumonia in France
BACKGROUND: The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. PURPOSE: To evaluate the French national experience using Chest CT for COVID-19, results of chest CT and RT-PCR were compared together and with th...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radiological Society of North America
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465292/ https://www.ncbi.nlm.nih.gov/pubmed/32870139 http://dx.doi.org/10.1148/radiol.2020202568 |
_version_ | 1783577556202553344 |
---|---|
author | Herpe, Guillaume Lederlin, Mathieu Naudin, Mathieu Ohana, Mickaël Chaumoitre, Kathia Gregory, Jules Vilgrain, Valérie Freitag, Cornelia Anna De Margerie-Mellon, Constance Flory, Violaine Ludwig, Marie Mondot, Lydiane Fitton, Isabelle Jacquier, Alexis Raymond, Robert Ardilouze, Paul Petit, Isabelle Gervaise, Alban Bayle, Olivier Crombe, Arielle Mekuko sokeng, Magloire Thomas, Clément Henry, Geraldine Bliah, Virginie Le Tat, Thomas Guillot, Marc-Samir Gendrin, Paul Garetier, Marc Bertolle, Estelle Montagne, Catherine Langlet, Benjamin Kalaaji, Abdulrazak Kayayan, Hampar Desmots, Florian Dhaene, Benjamin Saulnier, Pierre-Jean Guillevin, Remy Bartoli, Jean-Michel Beregi, Jean-Paul Tasu, Jean Pierre |
author_facet | Herpe, Guillaume Lederlin, Mathieu Naudin, Mathieu Ohana, Mickaël Chaumoitre, Kathia Gregory, Jules Vilgrain, Valérie Freitag, Cornelia Anna De Margerie-Mellon, Constance Flory, Violaine Ludwig, Marie Mondot, Lydiane Fitton, Isabelle Jacquier, Alexis Raymond, Robert Ardilouze, Paul Petit, Isabelle Gervaise, Alban Bayle, Olivier Crombe, Arielle Mekuko sokeng, Magloire Thomas, Clément Henry, Geraldine Bliah, Virginie Le Tat, Thomas Guillot, Marc-Samir Gendrin, Paul Garetier, Marc Bertolle, Estelle Montagne, Catherine Langlet, Benjamin Kalaaji, Abdulrazak Kayayan, Hampar Desmots, Florian Dhaene, Benjamin Saulnier, Pierre-Jean Guillevin, Remy Bartoli, Jean-Michel Beregi, Jean-Paul Tasu, Jean Pierre |
author_sort | Herpe, Guillaume |
collection | PubMed |
description | BACKGROUND: The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. PURPOSE: To evaluate the French national experience using Chest CT for COVID-19, results of chest CT and RT-PCR were compared together and with the final discharge diagnosis used as reference standard. MATERIALS AND METHODS: A structured CT scan survey (NCT04339686) was sent to 26 hospital radiology departments in France between March 2 and April 24 2020. These dates correspond to the peak of the national COVID-19 epidemic. Radiology departments were selected to reflect the estimated geographical prevalence heterogeneities of the epidemic. All symptomatic patients suspected of having a COVID-19 pneumonia who underwent within 48 hours both initial chest CT and at least one RT-PCR testing were included. The final discharge diagnosis, based on multiparametric items, was recorded. Data for each center were prospectively collected and gathered each week. Test efficacy was determined by using Mann-Whitney Test, Student’s t-test, Chi-square test and Pearson’s correlation. A p value <.05 determined statistical significance. RESULTS: Twenty-six of 26 hospital radiology departments responded to the survey with 7500 patients entered; 2652 did not have RT-PCR results or had unknown or excess delay between RT-PCR and CT. After exclusions, 4824 patients (mean age 64, ± 19 yrs, 2669 males) were included. Using final diagnosis as the reference, 2564 of the 4824 patients were positive for COVID-19 (53%). Sensitivity, specificity, NPV and PPV of chest CT for diagnosing COVID-19 were 2319/2564 (90%, 95% confidence interval [CI]: 89, 91), 2056/2260 (91%, 95%CI: 91, 92%), 2056/2300 (89%, 95%CI; 87, 90%) and 2319/2524 (92%, 95%CI 91, 93%) respectively. There was no significant difference for chest CT efficacy among the 26 geographically separate sites, each with varying amounts of disease prevalence. CONCLUSION: Use of chest CT for the initial diagnosis and triage of suspected COVID-19 patients was successful. |
format | Online Article Text |
id | pubmed-7465292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Radiological Society of North America |
record_format | MEDLINE/PubMed |
spelling | pubmed-74652922020-09-02 Efficacy of Chest CT for COVID-19 Pneumonia in France Herpe, Guillaume Lederlin, Mathieu Naudin, Mathieu Ohana, Mickaël Chaumoitre, Kathia Gregory, Jules Vilgrain, Valérie Freitag, Cornelia Anna De Margerie-Mellon, Constance Flory, Violaine Ludwig, Marie Mondot, Lydiane Fitton, Isabelle Jacquier, Alexis Raymond, Robert Ardilouze, Paul Petit, Isabelle Gervaise, Alban Bayle, Olivier Crombe, Arielle Mekuko sokeng, Magloire Thomas, Clément Henry, Geraldine Bliah, Virginie Le Tat, Thomas Guillot, Marc-Samir Gendrin, Paul Garetier, Marc Bertolle, Estelle Montagne, Catherine Langlet, Benjamin Kalaaji, Abdulrazak Kayayan, Hampar Desmots, Florian Dhaene, Benjamin Saulnier, Pierre-Jean Guillevin, Remy Bartoli, Jean-Michel Beregi, Jean-Paul Tasu, Jean Pierre Radiology Original Research BACKGROUND: The role and performance of chest CT in the diagnosis of the coronavirus disease 2019 (COVID-19) pandemic remains under active investigation. PURPOSE: To evaluate the French national experience using Chest CT for COVID-19, results of chest CT and RT-PCR were compared together and with the final discharge diagnosis used as reference standard. MATERIALS AND METHODS: A structured CT scan survey (NCT04339686) was sent to 26 hospital radiology departments in France between March 2 and April 24 2020. These dates correspond to the peak of the national COVID-19 epidemic. Radiology departments were selected to reflect the estimated geographical prevalence heterogeneities of the epidemic. All symptomatic patients suspected of having a COVID-19 pneumonia who underwent within 48 hours both initial chest CT and at least one RT-PCR testing were included. The final discharge diagnosis, based on multiparametric items, was recorded. Data for each center were prospectively collected and gathered each week. Test efficacy was determined by using Mann-Whitney Test, Student’s t-test, Chi-square test and Pearson’s correlation. A p value <.05 determined statistical significance. RESULTS: Twenty-six of 26 hospital radiology departments responded to the survey with 7500 patients entered; 2652 did not have RT-PCR results or had unknown or excess delay between RT-PCR and CT. After exclusions, 4824 patients (mean age 64, ± 19 yrs, 2669 males) were included. Using final diagnosis as the reference, 2564 of the 4824 patients were positive for COVID-19 (53%). Sensitivity, specificity, NPV and PPV of chest CT for diagnosing COVID-19 were 2319/2564 (90%, 95% confidence interval [CI]: 89, 91), 2056/2260 (91%, 95%CI: 91, 92%), 2056/2300 (89%, 95%CI; 87, 90%) and 2319/2524 (92%, 95%CI 91, 93%) respectively. There was no significant difference for chest CT efficacy among the 26 geographically separate sites, each with varying amounts of disease prevalence. CONCLUSION: Use of chest CT for the initial diagnosis and triage of suspected COVID-19 patients was successful. Radiological Society of North America 2020-09-01 /pmc/articles/PMC7465292/ /pubmed/32870139 http://dx.doi.org/10.1148/radiol.2020202568 Text en 2020 by the Radiological Society of North America, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Original Research Herpe, Guillaume Lederlin, Mathieu Naudin, Mathieu Ohana, Mickaël Chaumoitre, Kathia Gregory, Jules Vilgrain, Valérie Freitag, Cornelia Anna De Margerie-Mellon, Constance Flory, Violaine Ludwig, Marie Mondot, Lydiane Fitton, Isabelle Jacquier, Alexis Raymond, Robert Ardilouze, Paul Petit, Isabelle Gervaise, Alban Bayle, Olivier Crombe, Arielle Mekuko sokeng, Magloire Thomas, Clément Henry, Geraldine Bliah, Virginie Le Tat, Thomas Guillot, Marc-Samir Gendrin, Paul Garetier, Marc Bertolle, Estelle Montagne, Catherine Langlet, Benjamin Kalaaji, Abdulrazak Kayayan, Hampar Desmots, Florian Dhaene, Benjamin Saulnier, Pierre-Jean Guillevin, Remy Bartoli, Jean-Michel Beregi, Jean-Paul Tasu, Jean Pierre Efficacy of Chest CT for COVID-19 Pneumonia in France |
title | Efficacy of Chest CT for COVID-19 Pneumonia in France |
title_full | Efficacy of Chest CT for COVID-19 Pneumonia in France |
title_fullStr | Efficacy of Chest CT for COVID-19 Pneumonia in France |
title_full_unstemmed | Efficacy of Chest CT for COVID-19 Pneumonia in France |
title_short | Efficacy of Chest CT for COVID-19 Pneumonia in France |
title_sort | efficacy of chest ct for covid-19 pneumonia in france |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465292/ https://www.ncbi.nlm.nih.gov/pubmed/32870139 http://dx.doi.org/10.1148/radiol.2020202568 |
work_keys_str_mv | AT herpeguillaume efficacyofchestctforcovid19pneumoniainfrance AT lederlinmathieu efficacyofchestctforcovid19pneumoniainfrance AT naudinmathieu efficacyofchestctforcovid19pneumoniainfrance AT ohanamickael efficacyofchestctforcovid19pneumoniainfrance AT chaumoitrekathia efficacyofchestctforcovid19pneumoniainfrance AT gregoryjules efficacyofchestctforcovid19pneumoniainfrance AT vilgrainvalerie efficacyofchestctforcovid19pneumoniainfrance AT freitagcorneliaanna efficacyofchestctforcovid19pneumoniainfrance AT demargeriemellonconstance efficacyofchestctforcovid19pneumoniainfrance AT floryviolaine efficacyofchestctforcovid19pneumoniainfrance AT ludwigmarie efficacyofchestctforcovid19pneumoniainfrance AT mondotlydiane efficacyofchestctforcovid19pneumoniainfrance AT fittonisabelle efficacyofchestctforcovid19pneumoniainfrance AT jacquieralexis efficacyofchestctforcovid19pneumoniainfrance AT raymondrobert efficacyofchestctforcovid19pneumoniainfrance AT ardilouzepaul efficacyofchestctforcovid19pneumoniainfrance AT petitisabelle efficacyofchestctforcovid19pneumoniainfrance AT gervaisealban efficacyofchestctforcovid19pneumoniainfrance AT bayleolivier efficacyofchestctforcovid19pneumoniainfrance AT crombearielle efficacyofchestctforcovid19pneumoniainfrance AT mekukosokengmagloire efficacyofchestctforcovid19pneumoniainfrance AT thomasclement efficacyofchestctforcovid19pneumoniainfrance AT henrygeraldine efficacyofchestctforcovid19pneumoniainfrance AT bliahvirginie efficacyofchestctforcovid19pneumoniainfrance AT letatthomas efficacyofchestctforcovid19pneumoniainfrance AT guillotmarcsamir efficacyofchestctforcovid19pneumoniainfrance AT gendrinpaul efficacyofchestctforcovid19pneumoniainfrance AT garetiermarc efficacyofchestctforcovid19pneumoniainfrance AT bertolleestelle efficacyofchestctforcovid19pneumoniainfrance AT montagnecatherine efficacyofchestctforcovid19pneumoniainfrance AT langletbenjamin efficacyofchestctforcovid19pneumoniainfrance AT kalaajiabdulrazak efficacyofchestctforcovid19pneumoniainfrance AT kayayanhampar efficacyofchestctforcovid19pneumoniainfrance AT desmotsflorian efficacyofchestctforcovid19pneumoniainfrance AT dhaenebenjamin efficacyofchestctforcovid19pneumoniainfrance AT saulnierpierrejean efficacyofchestctforcovid19pneumoniainfrance AT guillevinremy efficacyofchestctforcovid19pneumoniainfrance AT bartolijeanmichel efficacyofchestctforcovid19pneumoniainfrance AT beregijeanpaul efficacyofchestctforcovid19pneumoniainfrance AT tasujeanpierre efficacyofchestctforcovid19pneumoniainfrance |